TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 NOK)
| Closing information | 2025/09 | 2024/09 | 2023/09 |
| Turnover |
5,470
|
6,087
|
6,479 |
| Financial expenses |
29
|
0
|
0 |
| Earnings before taxes |
3,619
|
4,305
|
4,498 |
| EBITDA |
3,622
|
3,844
|
4,104 |
| Total assets |
28,076
|
26,426
|
21,798 |
| Current assets |
3,216
|
2,925
|
8,493 |
| Current liabilities |
1,307
|
2,610
|
2,805 |
| Equity capital |
25,974
|
23,239
|
18,669 |
| - share capital |
53
|
52
|
49 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Solvency |
92.5%
|
87.9%
|
85.6% |
| Turnover per employee |
2,735
|
3,044
|
3,240 |
| Profit as a percentage of turnover |
66.2%
|
70.7%
|
69.4% |
| Return on assets (ROA) |
13.0%
|
16.3%
|
20.6% |
| Current ratio |
246.1%
|
112.1%
|
302.8% |
| Return on equity (ROE) |
13.9%
|
18.5%
|
24.1% |
| Change turnover |
-732
|
-794
|
493 |
| Change turnover % |
-12%
|
-12%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/09 | 2024/09 | 2023/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.